Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

66 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cost-Effectiveness of Three Different New-Generation Drug-Eluting Stents in the Randomised BIO-RESORT Trial at 3 Years.
Ploumen EH, Wolcherink MJO, Buiten RA, Pinxterhuis TH, Doggen CJM, Schotborgh CE, Danse PW, Scholte M, van Houwelingen KG, Zocca P, Pouwels XGLV, von Birgelen C. Ploumen EH, et al. Among authors: scholte m. Pharmacoecon Open. 2024 Oct 29. doi: 10.1007/s41669-024-00539-x. Online ahead of print. Pharmacoecon Open. 2024. PMID: 39472363 Free article.
Ethnic minorities treated with new-generation drug-eluting coronary stents in two European randomised clinical trials.
Ploumen EH, Semedo E, Doggen CJM, Schotborgh CE, Anthonio RL, Danse PW, Benit E, Aminian A, Stoel MG, Hartmann M, van Houwelingen KG, Scholte M, Roguin A, Linssen GCM, Zocca P, von Birgelen C. Ploumen EH, et al. Among authors: scholte m. Neth Heart J. 2024 Jun;32(6):254-261. doi: 10.1007/s12471-024-01873-9. Epub 2024 May 22. Neth Heart J. 2024. PMID: 38776038 Free PMC article.
Challenges in the Assessment of a Disease Model in the NICE Single Technology Appraisal of Tirzepatide for Treating Type 2 Diabetes: An External Assessment Group Perspective.
Scholte M, Ramaekers B, Danopoulos E, Grimm SE, Fernandez Coves A, Tian X, Debray T, Chen J, Stirk L, Croft R, Joore M, Armstrong N. Scholte M, et al. Pharmacoeconomics. 2024 Aug;42(8):829-832. doi: 10.1007/s40273-024-01394-8. Epub 2024 May 8. Pharmacoeconomics. 2024. PMID: 38717708 Free PMC article. No abstract available.
Author Correction: The IDEAL framework for surgical robotics: development, comparative evaluation and long-term monitoring.
Marcus HJ, Ramirez PT, Khan DZ, Layard Horsfall H, Hanrahan JG, Williams SC, Beard DJ, Bhat R, Catchpole K, Cook A, Hutchison K, Martin J, Melvin T, Stoyanov D, Rovers M, Raison N, Dasgupta P, Noonan D, Stocken D, Sturt G, Vanhoestenberghe A, Vasey B, McCulloch P; IDEAL Robotics Colloquium. Marcus HJ, et al. Nat Med. 2024 Apr;30(4):1213. doi: 10.1038/s41591-024-02836-8. Nat Med. 2024. PMID: 38297095 Free article. No abstract available.
The IDEAL framework for surgical robotics: development, comparative evaluation and long-term monitoring.
Marcus HJ, Ramirez PT, Khan DZ, Layard Horsfall H, Hanrahan JG, Williams SC, Beard DJ, Bhat R, Catchpole K, Cook A, Hutchison K, Martin J, Melvin T, Stoyanov D, Rovers M, Raison N, Dasgupta P, Noonan D, Stocken D, Sturt G, Vanhoestenberghe A, Vasey B, McCulloch P; IDEAL Robotics Colloquium. Marcus HJ, et al. Nat Med. 2024 Jan;30(1):61-75. doi: 10.1038/s41591-023-02732-7. Epub 2024 Jan 19. Nat Med. 2024. PMID: 38242979 Review.
Final 5-Year Report of the Randomized BIO-RESORT Trial Comparing 3 Contemporary Drug-Eluting Stents in All-Comers.
Ploumen EH, Pinxterhuis TH, Buiten RA, Zocca P, Danse PW, Schotborgh CE, Scholte M, Gin RMTJ, Somi S, van Houwelingen KG, Stoel MG, de Man HAF, Hartmann M, Linssen GCM, van der Heijden LC, Kok MM, Doggen CJM, von Birgelen C. Ploumen EH, et al. Among authors: scholte m. J Am Heart Assoc. 2022 Nov 15;11(22):e026041. doi: 10.1161/JAHA.122.026041. Epub 2022 Nov 8. J Am Heart Assoc. 2022. PMID: 36346050 Free PMC article. Clinical Trial.
66 results